Sodium nitroprusside injection immediately before balloon inflation during percutaneous coronary intervention.

BACKGROUND: No reflow or slow flow frequently occurs during percutaneous coronary inter-vention (PCI) and it is associated with adverse outcomes. Strategies should be undertaken to prevent its occurrence. AIM: To observe whether conventional target intracoronary administration of sodium nitroprusside immediately before balloon inflation can reduce the incidence of no reflow and slow flow, which are defined as thrombolysis in myocardial infarction flow grade ≤ II during PCI. METHODS: A retrospective study was conducted in 740 patients with coronary artery disease admitted to Gansu Provincial Hospital of Traditional Chinese Medicine between January 2016 and October 2020. Among them, 360 patients receiving sodium nitroprusside immediately before balloon inflation during PCI were enrolled in an experimental group between January 2019 and October 2020 and 380 patients receiving sodium nitroprusside after incident no reflow and slow flow during PCI were enrolled in a control group between January 2016 and January 2019. The occurrence of no reflow and slow flow was compared between the two groups and left ventricular end-diastolic diameter (LVEDD) and left ventricular ejection fraction (LVEF) were detected 1 mo after the operation. RESULTS: After treatment, the proportion of patients with thrombolysis in myocardial infarction flow grades 0 to II was lower in the experimental group than in the control group (P < 0.05). At 1 mo after treatment, LVEDD was lower and LVEF was higher in the experimental group than in the control group (P < 0.05). In terms of incidence of adverse cardiovascular events within 1 mo after treatment, in the experimental group, malignant arrhythmia occurred in three patients, intractable myocardial ischemia in three, congestive heart failure in four, and recurrent myocardial infarction in five; one patient died. In the control group, malignant arrhythmia occurred in eight patients, intractable myocardial ischemia in five, congestive heart failure in seven, and recurrent myocardial infarction in 14; two patients died. The incidence of adverse cardiovascular events was 4.4% in experimental group which was lower than that of the control group at 1 mo after operation (9.5%; P < 0.05). CONCLUSION: Administration of sodium nitroprusside into target vessels immediately before balloon inflation can significantly reduce the incidence of no reflow and slow flow, improve LVEDD and LVEF, and reduce the incidence of adverse cardio-vascular events in patients treated by PCI. It is worthy of clinical promotion.

[Effects of straw mulching on soil moisture and watermelon yield in dryland].

To explore the effects of straw mulching on soil moisture and yield of watermelon, corn straw was used as mulching materials, and three straw mulch treatments were performed, i. e., whole mulch (WM), rows mulch (SM) and root domain mulch (RM), and non-mulching as control. The results indicated that WM and RM treatments increased significantly soil water storage in 0-120 cm of soil layer under root domain and rows compared with the control during watermelon growth period, and soil water storage of RM was higher than that of SM after growing tendril. Effects of all straw mulch treatments on soil moisture were most obvious from watermelon post-growing tendril to pre-swelling and maturity. With the growth and development of watermelon, the three straw mulch treatments improved soil moisture around root domain, resulting in increased watermelon yields. Compared with the CK, the WM, SM and RM treatments significantly improved the yield and the water use efficiency of watermelon by 24.8%, 11.5% and 15.1%, and 42.7%, 24.3% and 29.4%. The WM with 13500 kg x hm(-2) straw was recommended for watermelon production in arid areas due to its favorable effect on soil storage moisture, yield and water use efficiency.

[Effects of strip planting and fallow rotation on the soil and water loss and water use efficiency of slope farmland].

In order to enhance the soil water-retaining capacity of slope farmland and reduce its soil and water loss, a field study was conducted in 2007-2010 to examine the effects of strip planting and fallow rotation on the soil water regime, soil and water loss characteristics, and water use efficiency of a 10 degrees-15 degrees slope farmland in the arid area of southern Ningxia, Northwest China. Compared with the traditional no-strip planting, strip planting and fallow rotation increased the soil water content in 0-200 cm layer significantly, with an increment of 4.9% -7.0%. Strip planting and fallow rotation pattern could also effectively conserve the soil water in rain season, and obviously improve the soil water regime at crops early growth stages. As compared to no-strip planting, strip planting and fallow rotation increased the soil water content in 0-200 cm layer by 5.4%-8.5%, decreased the surface runoff by 0.7-3.2 m3 x hm(-2), sediment runoff by 0.2-1.9 t x hm(-2), and soil total N loss by 42.1% -73.3%, while improved the crop water use efficiency by 6.1% -24.9% and the precipitation use efficiency by 6.3% -15.3%.

A novel influenza A (H1N1) vaccine in various age groups.

BACKGROUND: There is an urgent need for a vaccine that is effective against the 2009 pandemic influenza A (H1N1) virus. METHODS: A split-virus, inactivated candidate vaccine against the 2009 H1N1 virus was manufactured, and we evaluated its safety and immunogenicity in a randomized clinical trial. Subjects were between 3 and 77 years of age, stratified into four age groups. The immunization schedule consisted of two vaccinations, 21 days apart. Subjects were injected with placebo or with vaccine, with or without alum adjuvant, at doses of 7.5 microg, 15 microg, or 30 microg. Serologic analysis was performed at baseline and on days 21 and 35. RESULTS: A total of 2200 subjects received one dose, and 2103 (95.6%) received the second dose, of vaccine or placebo. No severe adverse side effects associated with the vaccine were noted. In the nonadjuvanted-vaccine groups, injection-site or systemic reactions, most mild in nature, were noted in 5.5 to 15.9% of subjects. Among the subjects receiving 15 microg of nonadjuvanted vaccine, a hemagglutination-inhibition titer of 1:40 or more was achieved by day 21 in 74.5% of subjects between 3 and 11 years of age, 97.1% of subjects between 12 and 17 years, 97.1% of subjects between 18 and 60 years, and 79.1% of subjects 61 years of age or older; by day 35, the titer had been achieved in 98.1%, 100%, 97.1%, and 93.3% of subjects, respectively. The proportion with a titer of 1:40 or more was generally highest among the subjects receiving 30 microg of vaccine, with or without adjuvant. Vaccine without adjuvant was associated with fewer local reactions and greater immune responses than was vaccine with adjuvant. CONCLUSIONS: These data suggest that a single dose of 15 microg of hemagglutinin antigen without alum adjuvant induces a typically protective immune response in the majority of subjects between 12 and 60 years of age. Lesser immune responses were seen after a single dose of vaccine in younger and older subjects. (ClinicalTrials.gov number, NCT00975572).

[Effect of vinblastine nanoparticles on antiproliferation in human glioma cell lines BT325].

OBJECTIVE: To compare antiproliferation effects of vinblastine nanopraticles and vinblastine water solution in human glioma cell lines BT325. METHOD: Vinblastine nanoparticles were prepared by emulsion polymerization process and using dextran as a stabilizing agent. It was characterized by means of morphology, size, drug entrapment efficiency and loading efficiency. Human glioma cell lines BT325 were treated with different concentrations of vinblastine nanoparticles and vinblastine water solution for 48 h, Antiproliferation effect was measured by MTT method. Morphological changes were observed by inverted microscope, transmission electron microscope and scanning electron microscope. RESULT: Mean diameter of VLB-PBCA-NP was about 74.4 nm, and drug entrapment efficiency and loading efficiency was 78.47% and 39.24%, respectively. Cell growth inhibition rate of vinblastine nanoparticles group and vinblastine water solution group in a concentration range (5-5 000 g x L(-1)) for 48 h was 41%, 49%, 73%, 83% and 28%, 33%, 54%, 60% respectively. Entrapment of VLB in NPS may distinctly degrade absorbency as compared to free drugs. Glioma cell BT325 which treated with VLB water solution were initial stage of apoptosis, and apoptosis body were forming. But VLB NPS-treated BT325 cells were intermediate or end stage, and missed structure integrality. CONCLUSION: VLB-PBCA-NP and VLB water solution could inhibit the growth of human glioma cell lines BT325, and VLB nanoparticles have stronger inhibition effect compared with VLB water solution in the same dose. PBCA may be effective as promising carrier for the transport of vinblastine into the glioma cells.